Table 3.
Investigations | Utility |
---|---|
Weight | Optimization of medications according to weight |
Oxygen saturation | Distinguish cyanotic CHD with increased pulmonary blood flow, from cyanotic CHD; assess worsening hemodynamics and need of intervention in TOF physiology |
Blood pressure | To assess optimal hypertension control following relief of aortic obstruction in children with coarctation of aorta and aortoarteritis |
Hemoglobin | Decide blood transfusion in patients with heart failure and cyanotic spells |
ASLO, CRP, ESR | To assess recurrence of acute rheumatic fever in children with RHD |
CRP, ESR | To assess recurrence of disease activity in patients with Takayasu arteritis |
PT/INR | Optimisation of anticoagulation in patients with prosthetic heart valve implantation |
ECG | For rhythm assessment in patients with pacemaker implantation |
ASLO Antistreptolysin O; CHD Congenital heart disease; CRP C-reactive protein; ECG Electrocardiogram; ESR Erythrocyte sedimentation rate; PT/INR Prothrombin time/ International normalised ratio; RHD Rheumatic heart disease; TOF Tetralogy of Fallot